Athira Pharma, Inc. Annual Costs and Expenses in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Athira Pharma, Inc. quarterly/annual Costs and Expenses history and growth rate from 2019 to 2023.
  • Athira Pharma, Inc. Costs and Expenses for the quarter ending September 30, 2024 was $29.6M, a 15.5% decline year-over-year.
  • Athira Pharma, Inc. Costs and Expenses for the twelve months ending September 30, 2024 was $114M, a 11.6% decline year-over-year.
  • Athira Pharma, Inc. annual Costs and Expenses for 2023 was $125M, a 20.6% increase from 2022.
  • Athira Pharma, Inc. annual Costs and Expenses for 2022 was $104M, a 62.5% increase from 2021.
  • Athira Pharma, Inc. annual Costs and Expenses for 2021 was $64M, a 220% increase from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Annual (USD)
Costs and Expenses, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $125M +$21.5M +20.6% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-22
2022 $104M +$40M +62.5% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-22
2021 $64M +$44M +220% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-23
2020 $20M +$14.5M +267% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-28
2019 $5.45M Jan 1, 2019 Dec 31, 2019 10-K 2021-03-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.